CS 1544-0975
Nonggongdanji-gil, Hongcheon-eup, Hongcheon-gun, Gangwon-do, Republic of Korea
TEL 033-435-4962
bgn4@bifido.com
ContactGet in touch helps us to
understand you better
Bifidobacterium longum
Global patented Bifidobacterium strain with
inhibition of rotavirus infection of infants
Bifidobacterium longum BORI showed 99% inhibition of the rotavirus infection in the experimental model. It was identified as a single protein named BORI (Bifidobacterium Original Rotavirus Inhibition) by our research team.
USA
NDI
(New Dietary Ingredient) approved by FDA [NDI 1082]
USA
GRAS
(Generally Recognized As Safe) approved by FDA [GRN 000813]
USA
Patented strain probiotics.
KOREA
Patented strain probiotics.
KOREA
Halal certificate recognized by Korea Muslim Federation Halal Committee.
Europe
Recognized by the European Food Safety Authority with Qualified Presumption of Safety (QPS)
Australia
Included in “Approved Terminology for Medicines Section – Biological List” by TGA
Canada
Can be used as Medicinal Ingredients of Natural Health Product
CHINA
Recognized by CFDA used in food
B. longum BORI, originated from a breast fed infant, is well documented regarding clinical evidence for its health promoting effects by various researchers of universities and hospitals and have been featured in the international textbooks of microbiology.
Encyclopedia of Food and Health
Bergey's Manual of
Systematic Bacteriology:
Volume 5: The Actinobacteria
The Bifidobact
eria and Related Organisms
Advances in Nutraceutical
Applications in Cancer
Carbohydrate-Active
Enzymes
Be kept in an airtight container
and stored at a temperature not
exceeding 8℃